References
- El-Menyar A, Mekkodathil A, Al-Thani H. Diagnosis and management of gastrointestinal stromal tumors: an up-to-date literature review. J Cancer Res Ther. 2017;13(6):889–900. doi:10.4103/0973-1482.177499.
- Liegl-Atzwanger B, Fletcher JA, Fletcher CD. Gastrointestinal stromal tumors. Virchows Arch. 2010;456(2):111–127. doi:10.1007/s00428-010-0891-y.
- DeMatteo RP, Lewis JJ, Leung D, Mudan SS, Woodruff JM, Brennan MF. Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Ann Surg. 2000;231(1):51–58. doi:10.1097/00000658-200001000-00008.
- Akiyama K, Numaga J, Kagaya F, Takazawa Y, Suzuki S, Koseki N, et al. Case of optic nerve involvement in metastasis of a gastrointestinal stromal tumor. Jpn J Ophthalmol. 2004;48(2):166–168. doi:10.1007/s10384-003-0028-9.
- Li LF, Tse YH, Ho SL, Yan KW, Lui WM. Duodenal GIST metastasized to skull and orbit managed by surgery: a case report. Asian J Surg. 2011;34(4):181–184. doi:10.1016/j.asjsur.2011.11.001.
- Woo D, Leong J, Waring D, Sharma A, Martin P. Orbital gastrointestinal stromal tumor metastasis. Orbit. 2012;31(2):129–131. doi:10.3109/01676830.2011.638100.
- Roelofs KA, Medlicott S, Henning JW, Weis E. Gastrointestinal stromal tumor metastasis to the orbit. Ophthalmic Plast Reconstr Surg. 2018;34(4):e131–e133. doi:10.1097/IOP.0000000000001144.
- Kim YJ, Lee WJ, Won CH, Choi JH, Lee MW. Metastatic cutaneous duodenal gastrointestinal stromal tumor: a possible clue to multiple metastases. Ann Dermatol. 2018;30(3):345–347. doi:10.5021/ad.2018.30.3.345.
- Yu Y, Ji X, Li W, Wu C. Orbital metastasis from a gastrointestinal stromal tumor: a case report. Am J Ophthalmol Case Rep. 2019;16:100528. doi:10.1016/j.ajoc.2019.100528.
- Hirota S, Isozaki K, Moriyama Y, Hashimoto K, Hishida T, Ishiguro S, et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science. 1998 23;279(5350):577–580. doi:10.1126/science.279.5350.577.
- West RB, Corless CL, Chen X, Rubin BP, Subramanian S, Montgomery K, et al. The novel marker, DOG1, is expressed ubiquitously in gastrointestinal stromal tumors irrespective of KIT or PDGFRA mutation status. Am J Pathol. 2004;165(1):107–113. doi:10.1016/S0002-9440(10)63279-8.
- Eisenberg BL. The SSG XVIII/AIO trial: results change the current adjuvant treatment recommendations for gastrointestinal stromal tumors. Am J Clin Oncol. 2013;36(1):89–90. doi:10.1097/COC.0b013e31827a7f55.
- Johnston FM, Kneuertz PJ, Cameron JL, Sanford D, Fisher S, Turley R, et al. Presentation and management of gastrointestinal stromal tumors of the duodenum: a multi-institutional analysis. Ann Surg Oncol. 2012;19(11):3351–3360. doi:10.1245/s10434-012-2551-8.